Yimei Ou

机构：Sun Yat-sen University, Hunan Normal University, Anhui Medical University, Chengdu Medical College, First Affiliated Hospital of Anhui Medical University, Sun Yat-sen University Cancer Center, Hunan Provincial People's Hospital · ORCID：0000-0002-6483-2661

发表论文 13 篇 · 总被引 156 次 · h-index 5

代表论文

• Apatinib enhanced anti-tumor activity of cisplatin on triple-negative breast cancer through inhibition of VEGFR-2 (2019 · Pathology - Research and Practice · 被引 39)
• Regulatory effects of lncRNA ATB targeting miR‐200c on proliferation and apoptosis of colorectal cancer cells (2019 · Journal of Cellular Biochemistry · 被引 38)
• SRPX2 promotes cell migration and invasion via FAK dependent pathway in pancreatic cancer. (2015 · PubMed · 被引 26)
• Saikosaponin-d suppresses cell growth in renal cell carcinoma through EGFR/p38 signaling pathway (2017 · Neoplasma · 被引 19)
• SRPX2 boosts pancreatic cancer chemoresistance by activating PI3K/AKT axis (2020 · Open Medicine · 被引 17)
• [Protective effect of ulinastatin combined with dexmedetomidine against hepatic ischemia-reperfusion injury in laparoscopic hepatectomy for liver cancer and cirrhosis: a randomized controlled trial]. (2022 · PubMed · 被引 5)